The report of the All-Party Group on Global Tuberculosis gives grounds for optimism; although the task is huge it provides a coherent set of recommendations that can be taken on by a new public health body seeking to demonstrate its leadership and effectiveness. Successfully leading the strategy to eliminate tuberculosis in the UK should be an agreed metric to measure the performance of Public Health England.
26 April 2013 | The Lancet (editorial)
In a new Report a group of MPs is calling on the UK Government for a two-fold approach to tackling the increasing public health threat of tuberculosis (TB) which is being exacerbated by drug-resistant strains (DR-TB) in all parts of the world, including the UK.
15 April 2013 | UK All-Party Parliamentary Group on Global Tuberculosis
Health ministers from Swaziland and South Africa have agreed to radically change the diagnosis and treatment of the co-epidemic of TB/HIV in their countries.
22 March 2013 | Voice of America
The Union is marking World TB Day this year by publishing a new guide that offers clear, practical advice on one of the trickiest aspects of "stopping TB" – how to manage the estimated 310,000 patients who have multidrug-resistant TB (MDR-TB).
21 March 2013 | International Union Against Tuberculosis and Lung Disease
If measures to tackle multidrug-resistant tuberculosis (MDR-TB) are not significantly stepped up, including addressing barriers that prevent both research into better drug combinations and treatment scale up, MDR-TB rates will continue to increase worldwide and a historic opportunity to improve abysmal cure rates will have been squandered, medical humanitarian organisation Médecins Sans Frontières (MSF) warned today.
20 March 2013 | MSF
On World Tuberculosis Day the TB Europe Coalition called on the European Commission to substantially increase funding to fight tuberculosis in Europe. Tuberculosis causes not only illness and death, according to estimates, it costs EU Member States €15 million every week and €750 million every year.
20 March 2013 | TB Europe Coalition
WHO and the Global Fund to Fight AIDS, TB and Malaria said today that strains of tuberculosis with resistance to multiple drugs could spread widely and highlight an annual need of at least US$ 1.6 billion in international funding for treatment and prevention of the disease.
18 March 2013 | World Health Organization
The Stop TB Partnership’s Global Drug Facility has reduced the price of several second-line drugs it supplies for the treatment of multidrug resistant tuberculosis (MDR-TB) by up to 26% compared to 2011 prices, resulting in a decrease in the overall cost of treatment.
18 March 2013 | Stop TB Partnership
Bedaquiline (also known by its trade name, Sirturo, or as TMC207) is the first new drug from a new drug class to treat TB to be approved by the United States Food and Drug Administration (FDA) in over 40 years. This guide highlights important safety and efficacy data reported thus far and offers advocacy recommendations for activists to take forward.
12 March 2013 | Treatment Action Group
Once considered a disease on the decline, tuberculosis (TB) has seen a resurgence in Ukraine and several other post-Soviet countries that endured social and economic tumult after the collapse of the Soviet Union.
10 March 2013 | Doctors Without Borders